Denovo Biopharma
Denovo Biopharma is a privately held biotech company providing a novel biomarker solution to personalize drug development. The core technology is the industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples. This technology is especially useful for late stage clinical drugs that have completed trials with unsatisfactory efficacy. By identifying biomarkers correlated to patients' responsiveness to drug candidates retrospectively, our technology enables biotech and pharmaceutical companies to design new clinical trials in a targeted patient population to achieve significant efficacy and/or less adverse effects. Our platform can be broadly applied to biomarker discovery in many therapeutic areas, such as oncology, metabolic, cardiology, immunology and neurology.
Domain
denovobiopharma.com
Country
United StatesIndustry
BiopharmaEmployees
11-50
Last Funding
$11.8M
Founded
2010
Tech Stack (5 technologies)
Frequently Asked Questions
What technologies does Denovo Biopharma use?+
Denovo Biopharma uses 5 technologies including Swiper, jQuery, Animate.css.
What industry is Denovo Biopharma in?+
Denovo Biopharma operates in the Biopharma industry.
Where is Denovo Biopharma based?+
Denovo Biopharma is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026